Dianthus Therapeutics
DNTH
DNTH
70 hedge funds and large institutions have $419M invested in Dianthus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.09% less ownership
Funds ownership: 4.62% → 4.53% (-0.09%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
70
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$34.6M | |
| 2 | +$7.2M | |
| 3 | +$6.18M | |
| 4 |
Alkeon Capital Management
New York
|
+$5.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.61M |
Top Sellers
| 1 | -$21M | |
| 2 | -$2.6M | |
| 3 | -$880K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$659K |
| 5 |
SIM
Spark Investment Management
New York
|
-$408K |